The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...

The FDA has announced new requirements for safety labeling on all opioid pain medications that place renewed emphasis on the risks associated with their long-term use. According to a July 31 news ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.

A Monroe County woman faces a slew of charges after investigators say she used a fake cancer diagnosis to obtain thousands of ...

As lawmakers continue to debate banning hemp-derived THC, some rural Texans say it helps ease addiction, health concerns and ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant leaf.